A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Recruiting now · Phase 2
Conditions studied: Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease
In brief
This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH). Each eligible participant will receive standard of care (SOC) plus ROC-101 for a 24-week treatment period, followed by a long-term extension period of the study through the end of the program or marketing approval/authorization.
Key facts
- Study ID
- NCT07175038
- Run by
- AllRock Bio, Inc.
- People needed
- 40
- Starts
- 2025-10-01
- Expected to finish
- 2029-03-01
- Last updated by the study team
- 2026-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Pulmonary Specialists — Phoenix, Arizona, United States (enrolling)
- University of California Davis Health — Rancho Cordova, California, United States (enrolling)
- University of Colorado — Aurora, Colorado, United States (enrolling)
- George Washington University Medical — Washington D.C., District of Columbia, United States (enrolling)
- Mayo Clinic of Florida — Jacksonville, Florida, United States (enrolling)
- The University of Kansas Medical Center Research Institute — Kansas City, Kansas, United States (enrolling)
- University of Michigan — Ann Arbor, Michigan, United States (enrolling)
- Ohio State University — Columbus, Ohio, United States (enrolling)
- Bend Memorial Clinic — Bend, Oregon, United States (enrolling)
- Temple University — Philadelphia, Pennsylvania, United States (enrolling)
- Royal Prince Alfred Hospital — Camperdown, New South Wales, Australia (enrolling)
- Pulmonary Hypertension Research Queensland — Auchenflower, Queensland, Australia (enrolling)
- Peter Lougheed Centre — Calgary, Alberta, Canada (enrolling)
- London Health Ontario — London, Ontario, Canada (enrolling)
- CHU de BICETRE SERVICE PNEUMOLOGIE — Le Kremlin-Bicêtre, Val-de-Marne, France (enrolling)
- Medizinische Hochschule Hannover — Hanover, Lower Saxony, Germany (enrolling)
- Fondazione IRCCS Policlinico San Matteo — Pavia, Lombardy, Italy (enrolling)
- Pauls Stradins Clinical University Hospital — Riga, Latvia (enrolling)
- Hospital Universitario 12 de Octubre — Madrid, Madrid, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.